Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02459106 · ClinicalTrials.gov registry record
Effect of AT-derived miRNA on the Biology and Insulin Sensitivity of Skeletal Muscle in Humans
A clinical trial, sponsored by AdventHealth Translational Research Institute.
- Completed
- Registry status
- 46
- Enrollment target
NCT02459106 is a clinical trial that has completed, run by AdventHealth Translational Research Institute. The registered enrollment target is 46 participants.
The verdict
NCT02459106 has completed, sponsored by AdventHealth Translational Research Institute.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
The purpose of this study is examine the effect of fat tissue-released miRNA on skeletal muscle and if abnormal fat tissue-released miRNA contributes to insulin resistance in obese individuals. This information will be important for our understanding of how the body's sugar metabolism is regulated and why people who are obese become insulin resistant and are more likely to develop type 2 diabetes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2015-05-27 |
| Est. Completion | 2024-12-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02459106
The ClinicalTrials.gov registry entry for NCT02459106 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02459106 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02459106 about?
NCT02459106 is a clinical study titled "Effect of AT-derived miRNA on the Biology and Insulin Sensitivity of Skeletal Muscle in Humans". The purpose of this study is examine the effect of fat tissue-released miRNA on skeletal muscle and if abnormal fat tissue-released miRNA contributes to insulin resistance in obese individuals. This information will be important for our understanding of how the body's sugar metabolism is regulated a...
What is the current status of trial NCT02459106?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2015-05-27. Estimated completion is 2024-12-19.
Who is sponsoring clinical trial NCT02459106?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.